C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/12 (2006.01) A61K 31/4725 (2006.01) A61P 25/04 (2006.01)
Patent
CA 2433603
Kappa opioid receptor antagonists are provided that yield significant improvements in functional binding assays to kappa opioid receptors relative to nor-BNI, and the use of these antagonists in treatment of disease states that are ameliorated by binding of the kappa opioid receptor such as heroin or cocaine addictions. These kappa opioid receptors have the formula: (see formula 1).
L'invention concerne des antagonistes du récepteur de kappa opioïdes permettant d'améliorer considérablement les essais fonctionnels de fixation à des récepteurs de kappa opioïdes concernant nor-BNI, ainsi que l'utilisation de ces antagonistes pour traiter des maladies améliorées par la fixation du récepteur de kappa opioïdes, telles que des dépendances à l'héroïne ou à la cocaïne.
Carroll F. Ivy
Mascarella S. Wayne
Thomas James B.
Norton Rose Canada S.e.n.c.r.l.,s.r.l./llp
Research Triangle Institute
LandOfFree
Kappa opioid receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kappa opioid receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kappa opioid receptor ligands will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2082015